Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis

被引：1
|
作者：
Sandborn, William J.
Van Assche, Gert A.
Reinisch, Walter
Colombel, Jean-Frederic
D'Haens, Geert R.
Wolf, Douglas C.
Kron, Martina
Tighe, Mary Beth
Lazar, Andreas
Thakkar, Roopal
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [21] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    LANCET, 2014, 384 (9940): : 285 - 286
  • [22] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert R.
    Hanauer, Stephen B.
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Lazar, Andreas
    GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
  • [23] Induction and maintenance of remission in ulcerative colitis
    Reimund, JM
    Bonaz, B
    Gompel, M
    Michot, F
    Moreau, J
    Veyrac, M
    Ballon, JW
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (10): : 992 - 1004
  • [24] Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 96 - +
  • [25] Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment
    Boschetti, Gilles
    Nancey, Stephane
    Moussata, Driffa
    Stefanescu, Carmen
    Roblin, Xavier
    Chauvenet, Marion
    Stroeymeyt, Karine
    Bouhnik, Yoram
    Flourie, Bernard
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 875 - 880
  • [26] Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy
    Melotti, L.
    Salice, M.
    Rinaldi, M.
    Dussias, N.
    Vanigli, N.
    Scaioli, E.
    Hrustemovic, H. Privitera
    Rizzello, F.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I567 - I568
  • [27] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [28] Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
    Jeon, Seong Ran
    Kim, Won Ho
    INTESTINAL RESEARCH, 2015, 13 (03) : 191 - 192
  • [29] Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
    Hyams, Jeffrey
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Subra
    Cohen, Stanley
    Markowitz, James
    Escher, Johanna C.
    Veereman-Wauters, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 391 - U169
  • [30] Predictors of mucosal healing during induction therapy in patients with acute moderate-to-severe ulcerative colitis
    Motobayashi, Maiko
    Matsuoka, Katsuyoshi
    Takenaka, Kento
    Fujii, Toshimitsu
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Iwamoto, Fumihiko
    Tsuchiya, Kiichiro
    Negi, Mariko
    Eishi, Yoshinobu
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (06) : 1004 - 1010
12345